Experts Praise Africa’s COVID-19 Response; India, Pakistan Increase Remdesivir Production; New Virus Hospital Opens In Yemen; NIH Communications Employee Departs After Anonymous Posts Attacking U.S. Health Officials
AP: As rich nations struggle, Africa’s virus response is praised (Anna, 9/22).
Thomson Reuters Foundation: Coronavirus rumors and regulations mar Burkina Faso’s malaria fight (Mednick, 9/21).
Financial Times: India and Pakistan ramp up remdesivir production under Gilead deal (Findlay, 9/21).
Reuters: Philippines’ Duterte eases overseas travel ban on health workers (Lema/Morales, 9/21).
Washington Post: As infections ebb, Japan hopes it has cracked the covid code on coexisting with the virus (Denyer, 9/19).
AP: Poland seeks more flu vaccines amid shortage during pandemic (Gera, 9/22).
Reuters: Exclusive: E.U. in early talks with Italy’s ReiThera over potential vaccine supply deal — source (Parodi et al., 9/21).
Washington Post: Britain could face 50,000 coronavirus cases per day by mid-October, top government scientists warn (Adam, 9/21).
WIRED: Could a Century-Old TB Shot Protect Against Other Respiratory Diseases? (Vaidyanathan, 9/21).
The Guardian: Covid warnings ring out as Latin America bids to return to normality (Daniels et al., 9/19).
AP: Yemen gets new virus hospital after other facilities close (Olsen, 9/22).
Daily Beast: A Notorious COVID Troll Actually Works for Dr. Fauci’s Agency (Markay, 9/21).
New York Times: NIH Official Departs After Anonymous Posts Attacking Public Health Leaders (Montague, 9/21).
PRI: Atul Gawande: With right ‘political environment,’ U.S. can control the coronavirus (Hackel, 9/21).
STAT: Joe Biden’s campaign-trail challenge: Casting doubt on a Trump vaccine without fueling broader vaccine skepticism (Facher, 9/22).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.